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187of positron emission tomography (PET)/computed tomography
(CT) to diagnose PHV endocarditis and the complementary value
of PET/CT as a major criterion in the modiﬁed Duke criteria. The
sensitivity and speciﬁcity of ﬂuorodeoxyglucose (FDG)-PET for
PHV endocarditis were 73% and 80%, respectively. When PET/
CT was added as a new major criterion to the modiﬁed Duke
criteria, the sensitivity rose from 70% to 97%. Clinically, the results
of this study are very important because PHV endocarditis is still
missed by echocardiography in up to 30% of cases (2,3). However,
the present study raises concerns about the speciﬁcity numbers,
early post-operative PHV endocarditis, and low sensitivity of
PET/CT imaging for vegetations.
A serious concern is the speciﬁcity of PET/CT because no PHV
controls were included as opposed to other similar studies con-
cerning the diagnostic value of FDG uptake around the implanted
cardiac devices (4,5). A normal FDG uptake pattern is crucial for
interpretation of the speciﬁcity and standardized uptake values
reported by Saby et al. (1), especially in the early post-operative
phase (<1 year). In this time frame, post-operative inﬂammation
may be a major issue and could result in false-positive imaging. The
authors did not discuss this point, probably because the median
post–PHV implantation period was 1,484 days (interquartile range:
526 to 3,396 days). As a consequence, the diagnostic value of PET/
CT in the early post-operative PHV phase was not investigated.
Furthermore, the authors did not elaborate on the role of retro-
spective electrocardiogram (ECG)-gated CT angiography (CTA)
for the detection of PHV endocarditis (6–8). Fagman et al. (6)
showed in a surgically conﬁrmed subpopulation of their study that
CTA was able to provide good detectability of both vegetations and
abscesses in patients with PHV endocarditis. CTA combined with
transesophageal echocardiography improved the diagnostic accuracy
of the imaging even more. In contrast, the results of the present
study showed that PET/CT missed a substantial number of vege-
tations (9 of 20 [45%]) in cases with no other echocardiographic
signs of PHV endocarditis. The authors discussed that this low
sensitivity of PET/CT for vegetations was caused by its low spatial
resolution. In our opinion, another reason for missing vegetations
was probably the high mobility of the valve leaﬂets resulting in
blurring of the PET signal beyond the point of detectability. The
moderate performance of PET/CT in the detection of anatomic
substrates can be substantially improved by CTA, which provides
both better spatial and temporal resolution compared with PET/CT
(which employs non–ECG-gated unenhanced low-dose CT).
This raises the question whether patients with a high suspicion of
PHV endocarditis and negative or inconclusive echocardiography
should undergo CTA or FDG-PET/CT. One could even argue that
combining both techniques is justiﬁed in a patient category with a
high in-hospital mortality (9). In our opinion, a tailor-made decision
has to be made on which technique should be used and what addi-
tional imaging is necessary. For example, in patientswith renal failure,
an additional PET/CT scan may be favorable; however, in patients
with an aortic PHV vegetation and suspected abscess, a CTA is
preferable because it may also provide noninvasive coronary angiog-
raphy. This may replace pre-operative invasive coronary angiography,
which is not desirable in a patient with aortic PHVvegetations (8,10).
In conclusion, FDG-PET imaging is a promising and welcome
new imaging tool for PHV endocarditis. However, speciﬁcity is a
concern because normal FDG uptake around PHVs, in particular
early after operation, is not known. Therefore, the proposed
addition of PET/CT to the Duke criteria as a major criterion is to
our opinion too premature. Furthermore, the sensitivity of FDG-PET for the detection of anatomic abnormalities such as vegeta-
tions is poor and needs to be compared with that of CTA.*Wilco Tanis, MD
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Computed Tomography for Diagnosis
of Prosthetic Valve EndocarditisWe thank Dr. Tanis and colleagues for their comments with regard
to our recently published report (1). They raised 3 important points
that we would like to discuss.
Table 1 PET/CT 2013 Modiﬁed Duke Criteria for the Diagnosis of Prosthetic Valve Endocarditis
Deﬁnite infective endocarditis
Pathological criteria
Microorganisms demonstrated by culture or histological examination of a vegetation, a vegetation that
has embolized, or an intracardiac abscess specimen
or
Pathological lesions; vegetation or intracardiac abscess conﬁrmed by histological examination showing
active endocarditis
Clinical criteria
2 major criteria
or
1 major criterion and 3 minor criteria
or
5 minor criteria
Possible infective endocarditis
1 major criterion and 1 minor criterion
or
3 minor criteria
Rejected infective endocarditis
Firm alternate diagnosis explaining evidence of infective endocarditis
or
Resolution of infective endocarditis syndrome with antibiotic therapy for 4 days
or
No pathological evidence of infective endocarditis at surgery or autopsy, with antibiotic therapy for 4 days
or
Does not meet criteria for possible infective endocarditis, as above
Major criteria
Blood culture positive for infective endocarditis
Typical microorganisms consistent with infective endocarditis from 2 separate blood cultures
Viridans streptococci, Streptococcus bovis, HACEK group, Staphylococcus aureus
or
Community-acquired enterococci, in the absence of a primary focus
or
Microorganisms consistent with infective endocarditis from persistently positive blood cultures,
deﬁned as follows:
2 positive cultures of blood samples drawn >12 h apart
or
All of 3 or a majority of 4 separate cultures of blood (with ﬁrst and last samples drawn 1 h apart)
Single positive blood culture for Coxiella burnetii or antiphase I IgG antibody titer >1:800
Evidence of endocardial involvement
Echocardiogram (TTE and/or TEE) positive for infective endocarditis deﬁned as follows
Oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets,
or on implanted material in the absence of an alternative anatomic explanation
or
Abscess
or
New partial dehiscence of prosthetic valve
or
New valvular regurgitation (worsening or changing of pre-existing murmur not sufﬁcient)
Positive 18F-FDG PET/CT: abnormal FDG uptake at the site of prosthetic valve*
Minor criteria
Predisposition, predisposing heart condition, or injection drug use
Fever; temperature >38C
Vascular phenomena: major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial
hemorrhage, conjunctival hemorrhages, Janeway lesions
Immunologic phenomena: glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor
Microbiological evidence: positive blood culture but does not meet a major criterion as noted above or
serological evidence of active infection with organism consistent with infective endocarditis
*This criterion should be considered only in patients with a prosthetic valve implantation >1 month earlier.
FDG ¼ ﬂuorodeoxyglucose; HACEK ¼ Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corro-
dens, and Kingella species; IgG ¼ immunoglobulin G; PET/CT ¼ positron emission tomography/computed tomography; TEE ¼ transesophageal
echocardiography; TTE ¼ transthoracic echocardiography.
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188First, in our study, we chose to include only patients with a
suspicion of prosthetic heart valve (PHV) endocarditis because our
primary objective was to test the impact of the implementation of
the positron emission tomography (PET)/computed tomography(CT) results in a new early Duke criteria classiﬁcation. The diag-
nostic value of this technique depends on the pre-test probability
and, thus, depends on the medical history of the patients, as well as
their clinical, microbiological, and imaging data. Because this
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189classiﬁcation has no use in the absence of endocarditis suspicion, we
did not include controls in this analysis. However, as suggested by
Dr. Tanis and colleagues, we now provide additional data.
We recently analyzed 10 consecutive PHV recipients (3 with
mechanical PHV and 7 with biological PHV) who underwent
PET/CT scanning as part of an investigation of malignancy to
determine the normal ﬂuorodeoxyglucose (FDG) pattern around
PHV. Of them, 2 patients (1 with mechanical PHV and 1 with
biological PHV) had an abnormal FDG uptake 13 and 16
months, respectively, after the PHV implantation, given a speci-
ﬁcity of 80%. This result is in accordance with what we have just
published (1).
Second, false-positive results of PET/CT may occur when this
technique is performed too early after the implantation of the
prosthetic valve. In the present study, the patients with cardiac
surgery performed <1 month earlier were not included to avoid
these false-positive results related to the early post-operative
inﬂammation around the sewing ring, as previously reported (2).
Nevertheless, 14 patients with a PHV implantation <1 year were
included in our work. In this subgroup, among the 3 patients with a
rejected ﬁnal diagnosis of endocarditis, none had an abnormal FDG
uptake. Their PHVs were implanted 66, 210, and 221 days before
the performance of PET/CT. However, the exact delay from which
an abnormal FDG uptake around a PHV could be interpreted as a
criterion of endocarditis remains to be deﬁned. Thus, we
acknowledge that the new PET/CT 2013 modiﬁed Duke criteria
should be used only in patients with suspicion of endocarditis >1
month after the implantation of the PHV. This comment is now
added to the criteria (Table 1).
Third, we agree with Dr. Tanis and colleagues when they
argued that retrospectively electrocardiogram-gated computed
tomography angiography (CTA) is an imaging modality that
may help in the diagnosis of PHV endocarditis, especially in
cases of periannular complications. Although encouraging re-
sults have been published (3,4), this technique has limitations
similar to echocardiography because it remains a morphological
imaging modality without functional data. This is a major issue
when microbiological data are negative and in the case of
absent or doubtful structural lesions. Indeed, CTA may miss
endocarditis at an early stage of the disease and thus may delay
the initiation of treatment (5). In the study of Fagman et al. (4),
of the 13 vegetations detected by transesophageal echocardiogra-
phy, only 7 (54%) were found by CTA. Moreover, all of the 7
vegetations detected by CTA were found by transesophageal
echocardiography (4). Thus, efforts should be made in the future to
develop good-quality imaging techniques that fuse the morpho-
logical accuracy of electrocardiogram-gated CTA (for the valves,
myocardium, and coronary anatomy) and the functional data of
PET (6).
In summary, we believe that we now have strong data to
consider an abnormal FDG uptake in PET/CT imaging as a
major criterion for PHV endocarditis. This result should be used
in patients with PHV implanted for >1 month and must be
interpreted in the clinical and the microbiological contexts.
Although future investigations will allow us to deﬁne the respec-
tive indications and the optimal timing of each new imaging
modality, we strongly believe that the time is coming to include
the results of PET/CT in the Duke criteria for the early diagnosis
of PHV endocarditis. Finally, PET/CT, CTA, and echocardi-
ography must not be considered as concurrent but rather as
complementary techniques. In the future, the 3 techniques willpotentially be used in patients with suspected or conﬁrmed PHV
endocarditis, depending on the clinical presentation and on the
results of initial echographic evaluation, in the era of multi-
modality modality imaging.*Franck Thuny, MD, PhD
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Aggressive ICD Programming
After MADIT-RIT
and ADVANCE III TrialsPowell et al. (1) reported interesting data on survival after shock
therapy in a large cohort of patients enrolled in the ALTITUDE
study. The analysis showed that following a ﬁrst implantable
cardioverter-deﬁbrillator (ICD) shock delivered for ventricular
episodes or atrial ﬁbrillation, there is an increased risk of death. The
same effect is not found when the shock is delivered for a benign
